Please check your internet connection and try again.
## Hepa-Merz (ornithine aspartate)
## Overview
Hepa-Merz is a combination of L-ornithine and L-aspartate, amino acids that play a role in the urea cycle and neurotransmitter metabolism. It is used in the management of hepatic encephalopathy.
## Primary Indications
* Treatment of latent and overt hepatic encephalopathy in patients with cirrhosis.
## Adult Dosing
* **Oral:** The typical dose is 3 sachets (each containing 9g ornithine aspartate) per day, divided into 3 doses. This corresponds to 27 grams of ornithine aspartate daily. Doses can be adjusted based on clinical response and tolerability.
* **Intravenous:** Dosing is highly variable and depends on the severity of hepatic encephalopathy and local protocols. A common regimen involves 5 grams of ornithine aspartate administered intravenously once or twice daily. **Specific IV dosing should be guided by institutional guidelines or the prescribing physician.**
## Pediatric Dosing
* The use of Hepa-Merz in pediatric patients has not been well-established. Dosage recommendations are generally not available for this population.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment beyond those inherent in the treatment of the underlying liver disease.
## Contraindications
* Hypersensitivity to ornithine aspartate or any component of the formulation.
* Severe renal failure (creatinine clearance < 30 mL/min) due to the risk of hyperornithinemia.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea. These are more common with oral administration.
* **Neurological:** Drowsiness or agitation in rare cases.
* **Musculoskeletal:** Arthralgia, myalgia.
* **Other:** Dizziness, headache, fatigue, skin rash.
## Key Drug Interactions
* There are no clinically significant drug interactions reported.
## Monitoring
* **Clinical:** Monitor for improvement in symptoms of hepatic encephalopathy (e.g., confusion, asterixis, altered mental status).
* **Laboratory:** Monitor electrolytes, renal function, and liver function tests periodically.
## Clinical Pearls
* Hepa-Merz facilitates ammonia detoxification by promoting the synthesis of urea in the liver and glutamine in the kidneys and muscles.
* Oral administration is typically divided into three daily doses to improve tolerability and compliance.
* Ensure adequate hydration, especially with intravenous administration.
* Effectiveness is often assessed by neurological status and ammonia levels.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols for definitive guidance.*
